Predictors of glycemic control in Japanese subjects with type 2 diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 57, Issue 4, 2008, Pages 453-457

  Tokuyama, Yoshiharu ^a   Ishizuka, Toshiharu ^a   Matsui, Kana ^b   Egashira, Toru ^b   Kanatsuka, Azuma ^a  

^a Chiba Central Medical Center   (Japan)

^b BML   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; HEMOGLOBIN A; INSULIN;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; JAPANESE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN SECRETION;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; REGRESSION ANALYSIS;

EID: 39849107333     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.11.004     Document Type: Article

References (24)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
3. American Diabetes Association. Implications of the United Kingdom Prospective Study. Diabetes Care 23 (2000) S27-S31
4. DeFronzo R.A. Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview. Diabetologia 35 (1992) 389-397
5. Kosaka K., Kuzuya T., Hagura R., et al. Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus. Diabetic Med 13 (1996) S109-S119
6. Kosaka K., Kuzuya T., Yoshinaga H., et al. A prospective study of health check examinees for the development of non-insulin-dependent diabetes mellitus: relationship of the incidence of diabetes with the initial insulinogenic index and degree of obesity. Diabetic Med 13 (1996) S120-S126
7. Festa A., Williams K., D'Agostino R., et al. The natural course of β-cell function in nondiabetic and diabetic individuals. Diabetes 55 (2006) 1114-1120
8. Eaton R.P., Allen R.C., Schade D.S., et al. Prehepatic insulin production in man: kinetics analysis using peripheral connecting peptide behavior. J Clin Endocrinol Metab 51 (1980) 520-528
9. Bergman R.N., Ider Y.Z., Bowden C.R., et al. Quantitative estimation of insulin sensitivity. Am J Physiol 236 (1979) E667-E677
10. Tokuyama Y., Sakurai K., Yagui K., et al. Pathophysiologic phenotypes of Japanese subjects with varying degrees of glucose tolerance: using the combination of C-peptide secretion rate and minimal model analysis. Metabolism 50 (2001) 812-818
11. World Health Organization. Diabetes mellitus: report of a WHO study group. WHO technical report series, no. 727 (1985), World Health Organization, Geneva, Switzerland
12. Tokuyama Y., Osawa H., Ishizuka T., et al. Serum resistin level is associated with insulin sensitivity in Japanese patients with type 2 diabetes mellitus. Metabolism 56 (2007) 693-698
13. Pacini G., and Bergman R.N. MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 23 (1986) 113-122
14. Dinneen S., Gerich J., and Rizza R. Carbohydrate metabolism in non-insulin-dependent diabetes mellitus. N Engl J Med 327 (1992) 707-713
15. Meyer C., Pimenta W., Woerle H.J., et al. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care 29 (2006) 1909-1914
16. Meyer C., Dostou J., Nadkarni V., et al. Effects of physiological hyperinsulinemia on systemic, renal and hepatic substrate metabolism. Am J Physiol 275 (1998) F915-F921
17. Dagogo-Jack S. Ethnic disparities in type 2 diabetes: pathophysiology and implications for prevention and management. J Natl Med Assoc 95 (2003) 774-789
18. Leahy J.L. Pathogenesis of type 2 diabetes mellitus. Arch Med Res 36 (2005) 197-209
19. Hatunic M., Burns N., Finucane F., et al. Contrasting clinical and cardiovascular risk status between early and later onset type 2 diabetes. Diab Vasc Dis Res 2 (2005) 73-75
20. Chuang L.M., Soegondo S., Soewondo P., et al. Comparison of the outcomes on control, type of management and complications status in early onset and late onset type 2 diabetes in Asia. Diabetes Res Clin Pract 71 (2006) 146-155
21. Hillier T.A., and Pedula K.L. Characteristics of an adult population with newly diagnosed type 2 diabetes. The relation of obesity and age of onset. Diabetes Care 24 (2001) 1522-1527
22. Elgzyri T., Almgren P., Eliasson M., et al. Progression and mortality in type 2 diabetes. Diabetologia 49 Suppl 1 (2006) 46
23. Vaxillaire M., and Froguel P. Genetic basis of maturity-onset diabetes of the young. Endocrinol Metab Clin N Am 35 (2006) 371-384
24. Molyneaux L., Constantino M., and Yue D. Strong family history predicts a younger age of onset for subjects diagnosed with type 2 diabetes. Diabetes Obes Metab 6 (2004) 187-194